Related Experiment Video
Updated: Jan 23, 2026

Creating Sub-50 Nm Nanofluidic Junctions in PDMS Microfluidic Chip via Self-Assembly Process of Colloidal Particles
Published on: March 13, 2016
Remotely controlled nanofluidic implantable platform for tunable drug delivery
Nicola Di Trani1, Antonia Silvestri, Giacomo Bruno
1Nanomedicine Department, Houston Methodist Research Institute, Houston, TX, USA. agrattoni@houstonmethodist.org.
This study introduces a novel implantable device for chronic disease management. It allows remote, adjustable drug delivery, improving treatment personalization and adherence for conditions like hypertension and rheumatoid arthritis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery Systems
Background:
- Chronic diseases necessitate lifelong management, but adherence to strict dosing schedules is challenging.
- Current treatments often fail to account for individual patient variability.
- Existing implantable devices lack flexible dosage and timing control.
Purpose of the Study:
- To develop a subcutaneously implantable, remote-controlled nanofluidic device for personalized drug delivery.
- To enable adjustable and on-demand administration of therapeutics for chronic conditions.
- To overcome limitations of conventional drug delivery systems in chronic disease management.
Main Methods:
- Development of a nanofluidic device controlled by a low-intensity electric field via Bluetooth.
- In vitro modulation of enalapril (hypertension) and methotrexate (rheumatoid arthritis) release rates.
- In vivo assessment of remote communication and device biocompatibility.
Main Results:
- Demonstrated in vitro control over drug release rates (increase, decrease, stop) for enalapril and methotrexate.
- Confirmed reliable remote communication and biocompatibility of the implantable device in vivo.
- The device enables continuous drug administration, avoiding abrupt fluctuations.
Conclusions:
- The developed nanofluidic device offers a flexible, remote-controlled solution for personalized chronic disease management.
- This technology has the potential to improve therapeutic efficacy and patient adherence.
- It lays the groundwork for a new platform for on-demand drug delivery systems.
More Related Videos
15:04Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
Published on: May 20, 2016
10:17Insect-machine Hybrid System: Remote Radio Control of a Freely Flying Beetle Mercynorrhina torquata
Published on: September 2, 2016
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Control Governance: Regulatory Bodies and Their Impact
Control System Problem
When forming a closed-loop system, issues can arise if the poles cross into the unstable region, leading to potential...